Stem Cell Therapy International, Inc. and Histostem Korea Announce $5 Million Financing Commitment
TAMPA, FL–(Marketwire – 11/03/09) – Stem Cell Therapy International Inc. (OTC.BB: SCII – News ) and its soon to be subsidiary, Histostem Ltd. of South Korea (”Histostem”), announced that they have entered into a definitive agreement for up to a $5 million investment commitment with Socius Life Science Capital Group, LLC. The Company’s plan is to have funds available no later than December 31 …
[Read the full article here]Related News:
Stem Cell Therapy International to merge with Histostem Korea
Stem Cell Therapy International, Inc. And Histostem Korea Announce Providing Hematopoietic Stem Cell To Queen Mary Hospital, Hong Kong
Stem Cell Therapy International, Inc. and Histostem Korea Announce Providing Hematopoietic Stem Cell to Queen Mary …